Specialist Mobile Wound Healing Clinic Goes on the Road to Provide Revolutionary New Treatments In a unique collaboration between award-winning Harley Street Skin clinic and Biotherapy Services Ltd., a state of the art mobile wound clinic will be on the road from October 5th. The first of...
At Biotherapy Services we are hugely excited by the proposal of the Medicines and Medical Device Bill introduced on 13/02/2020. Without this support of the UK Government, we would be unable to develop innovative point of care manufactured medicines providing important new treatment options for the people of...
Innovative biopharmaceutical company Biotherapy Services Ltd secures £3.0 million investment from Foresight £3.0 million investment from Foresight VCT and Foresight 4 VCT. Biotherapy Services Limited has developed a pioneering treatment for complex wounds and the product is in clinical trials for the treatment of diabetic...
Biotherapy Services appoints John Chiplin as Chairman We are pleased to announce the key appointment to the BTS Board of Dr John Chiplin PhD as Chairman. John is Managing Director of Newstar Ventures Ltd. and also Chairman of Scancell Holdings plc (LSE:SCLP) and has extensive UK...
8thMarch 2019 Biotherapy Services Limited Exciting Update RAPID-1 Diabetic Foot Ulcer [RAPID-1DFU] Randomised Controlled Trial The Board and Executive Management Team are delighted to announce that the treatment of patients has commenced on the RAPID-1DFU trial. The RAPID Biodynamic Haematogel treatment is the first-in-class, medicinal product under development for the...
Biotherapy Services Limited MHRA approves the RAPID-1DFU clinical trial Company is progressing as planned towards Q1/2019 clinical trials. 8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement...
Biotherapy Services Limited We are pleased to announce the appointment of James Rickard as Chief Scientific and Regulatory Officer James has over 17 years’ experience as a clinical pharmacist leading technical services and clinical trials within the NHS. Most recently James was the Deputy chief pharmacist for Barts...
Biotherapy Services Limited MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment. Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018 For further information,...